Overview: HEV Quantitative PCR TestIntroduction: The HEV Quantitative PCR Test quantifies hepatitis E viral RNA to monitor infection severity, preventing liver failure. Aligned with 2023 AASLD guidelines, it uses PCR for high sensitivity, aiding in infectious disease screening. This test is critical for guiding treatment, assessing disease progression, and improving outcomes in virology for patients with hepatitis E, particularly in severe or chronic cases in immunocompromised individuals.
Other Names: HEV RNA Quant Assay, Hepatitis E Viral Load Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: HEV RNA quantification began in the 2000s with PCR advancements. Quantitative PCR assays improved in the 2010s, enhancing infection monitoring.
Purpose: Monitors hepatitis E infection severity, guides treatment, and quantifies HEV RNA in patients to prevent liver failure.
Test Parameters: 1. HEV RNA (Quantitative)
Pretest Condition: No fasting required. Collect serum or plasma at any time. Report history of hepatitis E, symptoms like fatigue, or travel to endemic areas, and list medications.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fatigue, jaundice, or history of hepatitis E. Include current medications, travel history, and immunosuppression status.
Consent: Written consent required, detailing the tests purpose, monitoring implications, and potential need for treatment adjustments.
Procedural Considerations: Uses PCR to quantify HEV RNA levels. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for immunocompromised patients.
Factors Affecting Result Accuracy: Improper sample handling, contamination, or low viral load can affect results. Immunosuppression may alter RNA levels.
Clinical Significance: High HEV RNA levels indicate active infection, guiding treatment (e.g., ribavirin in chronic cases). Undetectable levels suggest resolution or low activity.
Specialist Consultation: Consult a hepatologist for result interpretation and treatment planning.
Additional Supporting Tests: Anti-HEV IgM, anti-HEV IgG, or liver function tests to monitor hepatitis E status.
Test Limitations: Low viral loads may be undetectable. Clinical correlation and serial testing are needed.
References: AASLD Hepatitis E Guidelines, 2023; Hepatology, Kamar N, 2022.
